1993
DOI: 10.1016/0360-3016(93)90233-l
|View full text |Cite
|
Sign up to set email alerts
|

Neutron versus photon irradiation for unresectable salivary gland tumors: Final report of an RTOG-MRC randomized clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
159
0
2

Year Published

1994
1994
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 265 publications
(169 citation statements)
references
References 27 publications
6
159
0
2
Order By: Relevance
“…Further therapy strategies recommend on a type-2 level of evidence [14] in cases of unresectable/inoperable locoregional disease neutron, heavy ions or proton radiotherapy. But there are still controversies concerning radiotherapy, on the one hand surgical resection and postoperative RT is recommended [15].…”
Section: Discussionmentioning
confidence: 99%
“…Further therapy strategies recommend on a type-2 level of evidence [14] in cases of unresectable/inoperable locoregional disease neutron, heavy ions or proton radiotherapy. But there are still controversies concerning radiotherapy, on the one hand surgical resection and postoperative RT is recommended [15].…”
Section: Discussionmentioning
confidence: 99%
“…Randomized trials have confirmed that neutron radiation achieves superior results to those of conventional photon radiation in the treatment of salivary gland tumors and prostate cancer (2,3). In addition, retrospective experience suggests that other tumors, such as utiresectable soft tissue and bone sarcomas are more effectively treated with fast neutrons compared to conventional photon treatment (4).…”
Section: Discussionmentioning
confidence: 99%
“…Fast neutron radiotherapy has been extensively studied in human trials with clear advantages demonstrated over conventional photon radiation for certain neoplasms, but only equivalent results in the majority of tumors (2)(3)(4)(5)(6)(7). BNCT has yet to develop 308 T. A. RUCHHOLZ ET AL into a clinically useful tool.…”
mentioning
confidence: 99%
“…Currently, there are only five operating centers worldwide, three of them in the United States. Areas where neutrons have shown potential benefits include salivary gland tumors (specifically, adenoid cystic carcinoma), [41][42][43] squamous cell carcinomas of the head and neck, 44,45 non-small cell lung cancer, 46 prostate cancer, [47][48][49] and sarcomas. 50 …”
Section: Fast Neutron Therapymentioning
confidence: 99%